Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Figure out How to Adjust Work, Life, and an Internet based Degree - 2Joshua Made Last-Second Seat Change That Saved His Life
- 3The Benefits of Effective money management for Your Youngsters' Future Monetary Prosperity
- 4‘Grit’ and relentless perseverance can take a toll on brain health − particularly for people facing social stresses like racism
- 5Most loved Specially prepared Espresso Mix: Which Meal Do You Adore the Most?
- A Manual for Extravagant Vehicles Available in 2024
- The Response to Independence from the rat race: Methodologies for Creating Financial momentum
- 'Euphoria' releases Season 3 photos with Zendaya, Sydney Sweeney, Jacob Elordi and others: See them
- Pope Leo XIV calls for urgent climate action and says God’s creation is 'crying out'
- Vote In favor of Your Favored Video Conferencing Administration
- Help Your Business with Master Web based Promoting Arrangements
- Kansas school officials report high student illness, dismiss early
- Health insurance premiums rose nearly 3x the rate of worker earnings over the past 25 years
- Astronomers may have spotted the 1st known 'superkilonova' double star explosion
